FI70212C - Analogifoerfarande foer framstaellning av terapeutiskt aktiva 2-aminolalkyl-5-pyridinoler - Google Patents

Analogifoerfarande foer framstaellning av terapeutiskt aktiva 2-aminolalkyl-5-pyridinoler Download PDF

Info

Publication number
FI70212C
FI70212C FI801411A FI801411A FI70212C FI 70212 C FI70212 C FI 70212C FI 801411 A FI801411 A FI 801411A FI 801411 A FI801411 A FI 801411A FI 70212 C FI70212 C FI 70212C
Authority
FI
Finland
Prior art keywords
formula
general formula
mixture
pyridinol
compounds
Prior art date
Application number
FI801411A
Other languages
English (en)
Finnish (fi)
Other versions
FI70212B (fi
FI801411A7 (fi
Inventor
Renat Herbert Mizzoni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI801411A7 publication Critical patent/FI801411A7/fi
Publication of FI70212B publication Critical patent/FI70212B/fi
Application granted granted Critical
Publication of FI70212C publication Critical patent/FI70212C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI801411A 1979-05-03 1980-04-30 Analogifoerfarande foer framstaellning av terapeutiskt aktiva 2-aminolalkyl-5-pyridinoler FI70212C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3566879A 1979-05-03 1979-05-03
US3566879 1979-05-03

Publications (3)

Publication Number Publication Date
FI801411A7 FI801411A7 (fi) 1980-11-04
FI70212B FI70212B (fi) 1986-02-28
FI70212C true FI70212C (fi) 1986-09-15

Family

ID=21884070

Family Applications (1)

Application Number Title Priority Date Filing Date
FI801411A FI70212C (fi) 1979-05-03 1980-04-30 Analogifoerfarande foer framstaellning av terapeutiskt aktiva 2-aminolalkyl-5-pyridinoler

Country Status (19)

Country Link
EP (1) EP0019739B1 (enrdf_load_stackoverflow)
JP (1) JPS55149260A (enrdf_load_stackoverflow)
AT (1) ATE8501T1 (enrdf_load_stackoverflow)
DD (1) DD150461A5 (enrdf_load_stackoverflow)
DE (1) DE3068577D1 (enrdf_load_stackoverflow)
DK (1) DK157540C (enrdf_load_stackoverflow)
ES (1) ES8104229A1 (enrdf_load_stackoverflow)
FI (1) FI70212C (enrdf_load_stackoverflow)
GB (1) GB2050380B (enrdf_load_stackoverflow)
GR (1) GR68206B (enrdf_load_stackoverflow)
HU (1) HU181115B (enrdf_load_stackoverflow)
IE (1) IE49712B1 (enrdf_load_stackoverflow)
IL (1) IL59978A (enrdf_load_stackoverflow)
MA (1) MA18964A1 (enrdf_load_stackoverflow)
NO (1) NO154130C (enrdf_load_stackoverflow)
OA (1) OA06528A (enrdf_load_stackoverflow)
PL (1) PL223984A1 (enrdf_load_stackoverflow)
PT (1) PT71176A (enrdf_load_stackoverflow)
ZW (1) ZW9680A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746670A (en) * 1986-04-11 1988-05-24 Ciba-Geigy Corporation Use of 2-aminoalkyl-5-pyridinols as nootropic agents and antidepressants
JP4732662B2 (ja) * 2000-04-06 2011-07-27 セイコーインスツル株式会社 電子時計の電池保持構造

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
IE49712B1 (en) 1985-11-27
FI70212B (fi) 1986-02-28
DK157540B (da) 1990-01-22
DD150461A5 (de) 1981-09-02
DK193180A (da) 1980-11-04
HU181115B (en) 1983-06-28
DK157540C (da) 1990-06-11
GR68206B (enrdf_load_stackoverflow) 1981-11-10
ATE8501T1 (de) 1984-08-15
MA18964A1 (fr) 1980-12-31
PT71176A (en) 1980-05-01
EP0019739A1 (de) 1980-12-10
IL59978A (en) 1984-03-30
NO154130B (no) 1986-04-14
IE800899L (en) 1980-11-03
OA06528A (fr) 1981-07-31
ZW9680A1 (en) 1980-11-26
EP0019739B1 (de) 1984-07-18
NO801267L (no) 1980-11-04
PL223984A1 (enrdf_load_stackoverflow) 1981-02-13
GB2050380B (en) 1983-07-20
NO154130C (no) 1986-07-23
JPS55149260A (en) 1980-11-20
IL59978A0 (en) 1980-07-31
JPS6365662B2 (enrdf_load_stackoverflow) 1988-12-16
GB2050380A (en) 1981-01-07
DE3068577D1 (en) 1984-08-23
FI801411A7 (fi) 1980-11-04
ES491055A0 (es) 1981-04-01
ES8104229A1 (es) 1981-04-01

Similar Documents

Publication Publication Date Title
FI67369B (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva derivat av 3,4-dehydroprolin
US3920728A (en) Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
DE69202876T2 (de) Inhibitoren von N-Myristoyltransferase, deren Verfahren zur Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen.
HRP930508A2 (en) Difenilpropilamina process for the preparation of the novel enylpropylamine derivatives
US5162538A (en) Antiviral new peptides
NZ307230A (en) Furo[3,4-c]pyrrole, isoindole or thieno[3,4-c]pyrrole derivatives and medicaments
FR2556343A1 (fr) Nouveaux derives d'aminoguanidine, procede pour leur preparation et medicaments les contenant
US4124593A (en) Aromatic dicarboximides
US4882316A (en) Pyrimidine derivatives
FI70212C (fi) Analogifoerfarande foer framstaellning av terapeutiskt aktiva 2-aminolalkyl-5-pyridinoler
US4260619A (en) 2-Aminoalkyl-5-pyridinols
DE69418110T2 (de) N-Heteroaryl substituierte Propanamid-Derivate brauchbar zur Behandlung cardiovascularer Krankheiten
US6197793B1 (en) Hemoregulatory compounds
US4283422A (en) 3-Amino-4-homoisotwistane derivatives
HRP960015A2 (en) Substituted indole derivatives
US3377359A (en) Amino derivatives, comprising heterocycles, their salts, and process for preparation
US2970159A (en) Hydrazine derivatives
SE443784B (sv) Nya foreningar med farmakologisk verkan
BG100218A (bg) Енантиомери на 4-(5-флуоро-2,3-дихидро-1н-инден-2-ил)- 1н-имидазол
FI85140C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1h-indol-4-yl)-bensamidderivat.
GB2050360A (en) 2-Aminoalkyl-5-pyridinols
US4816474A (en) Amino substituted thienothiopyran derivatives, composition containing them, and method of using them to stimulate presynaptic dopamine receptors
CA1135269A (en) 2-aminoalkyl-5-pyridinols, process for their manufacture, pharmaceutical preparations containing these compounds and their therapeutic application
GB1561516A (en) 1-(azacylic aralkoxyphenyl) - 2 - or - 3-(bis -arylalkylamino alkanes process for their manufacture and pharmaceutical preparation containint them
SE460969B (sv) Apovincaminsyraderivat, foerfarande foer framstaellning daerav och farmaceutiska kompositioner innehaallande dessa derivat

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: CIBA-GEIGY AG